Oxford Capital

News, insights, analysis and data

← Back to Oxford Capital profile

Oxford Capital related stories

All articles and analysis

  • Intent HQ gets funding led by Oxford Capital
    Angela Sormani- 1 May 2014

    Specialist UK-based growth capital investor, Oxford Capital, has led an investment in London-based software company, Intent HQ. Oxford Capital joins existing investor, Edge Performance VCT.

  • Oxford Capital backs Arkivum
    Iris Dorbian- 1 April 2014

    Arkivum has secured 1.9 million pounds in financing. Oxford Capital led the round with participation from return backers IP Group and Parkwalk Advisors. Based in the UK, Arkivum is a provider of digital archiving solutions.

  • Oxford Capital backs Arkivum
    Iris Dorbian- 1 April 2014

    Arkivum has secured 1.9 million pounds in financing. Oxford Capital led the round with participation from return backers IP Group and Parkwalk Advisors. Based in the UK, Arkivum is a provider of digital archiving solutions.

  • European people briefs, compiled for April 2014
    Staff Writer- 1 April 2014

    Corporate COO goes VC; New execs at Oxford; three join small-biz investor

  • Oxford Capital appoints infrastructure investment director
    Angela Sormani- 31 March 2014

    Oxford Capital has appointed Barney Rhys Jones as infrastructure investment director. He will manage Oxford Capital’s renewable energy and infrastructure asset portfolio and operational aspects of the investment management process.

  • Oxford Capital leads Linkdex funding round
    Angela Sormani- 26 March 2014

    Growth capital investor Oxford Capital has led a major funding round for Linkdex. Oxford Capital joins existing investor Amadeus Capital which backed the business from an early stage. Based in London and New York Linkdex is a web-based, enterprise platform for search engine optimisation (SEO), PR, social, content marketing and business intelligence.

  • Green Biologics raises Series B led by Sofinnova
    Angela Sormani- 4 December 2013

    UK-based Green Biologics has raised a $25 million Series B round led by Sofinnova Partners. Morgan Joseph TriArtisan was exclusive financial advisor to the company.

  • Sofinnova Partners leads Series B round for Green Biologics
    Iris Dorbian- 2 December 2013

    Green Biologics Ltd said Monday that it has received £15.4 million in Series B funding. Sofinnova Partners led the round with participation from Swire Pacific Limited, Capricorn Venture Partners, Oxford Capital Partners, Morningside Ventures and ConvergInce Holdings. Based in the UK, Green Biologics is a industrial biotechnology company.

  • Oxford Capital Exits Arieso in $85m Deal
    angela sormani- 13 March 2013

    Specialist growth capital investor Oxford Capital has exited mobile network optimisation business, Arieso, in an $85 million deal. The sale realised returns of up to 4.7x for investors.

  • Glide Pharma Adds $21.4M
    VCJ Staff- 26 February 2013

    Oxford, England-based Glide Pharma raised $21.4 million in new funding. The company, a pharmaceutical development and device company, is backed by investors including Invesco Perpetual. Glide Pharma will use the funds for manufacturing of its solid dose injector system.